J Visc Surg. 2019 Oct 24. pii: S1878-7886(19)30138-9. doi: 10.1016/j.jviscsurg.2019.09.004. [Epub ahead of print] Prudhomme M1, Legras A2, Delorme C3, Lansaman T4, Lanteri-Minet M5, Medioni J6, Navez M7, Perrot S8, Pickering G9, Serrie A10, Viel E11. Abstract Chronic postsurgical neuropathic
Neurostimulation methods in the treatment of chronic pain.
J Neural Transm (Vienna). 2019 Oct 21. doi: 10.1007/s00702-019-02092-y. [Epub ahead of print] Moisset X1, Lanteri-Minet M2,3, Fontaine D4. Abstract The goal of this narrative review was to give an up-to-date overview of the peripheral and central neurostimulation methods that
[Drug management of cancer-related peripheral neuropathic pain: A systematic review of the literature].
Bull Cancer. 2019 Sep;106(9):784-795. doi: 10.1016/j.bulcan.2019.04.009. Epub 2019 Jun 13. Medioni J1, Pickering G2, Delorme C3, Lansaman T4, Lanteri-Minet M5, Legras A6, Navez M7, Prudhomme M8, Serrie A9, Viel É10, Perrot S11. Abstract The objective of the present systematic literature
Patients’ Global Impression of Change in the management of peripheral neuropathic pain: Clinical relevance and correlations in daily practice.
Eur J Pain. 2019 Jul;23(6):1117-1128. doi: 10.1002/ejp.1378. Epub 2019 Mar 18. Perrot S1, Lantéri-Minet M2,3. Abstract BACKGROUND: Patient-Reported Outcome (PRO) instruments have been developed to evaluate pain management in daily practice; the Patients’ Global Impression of Change (PGIC) is particularly
QAPSA: post-marketing surveillance of capsaicin 8% patch for long-term use in patients with peripheral neuropathic pain in France.
Curr Med Res Opin. 2019 Mar;35(3):417-426. doi: 10.1080/03007995.2018.1558850. Epub 2019 Jan 7. Lantéri-Minet M1,2, Perrot S3. Abstract OBJECTIVE: To describe the characteristics of patients treated with the capsaicin 8% patch, prescribing conditions, long-term effects of repeat treatment on pain intensity
Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial.
Eur J Pain. 2018 Aug;22(7):1321-1330. doi: 10.1002/ejp.1221. Epub 2018 Apr 18. Kerckhove N1,2, Pereira B1, Soriot-Thomas S3, Alchaar H4, Deleens R5, Hieng VS6, Serra E3, Lanteri-Minet M1,4, Arcagni P7, Picard P1, Lefebvre-Kuntz D8, Maindet C9, Mick G10, Balp L11, Lucas
Network topology of NaV1.7 mutations in sodium channel-related painful disorders.
BMC Syst Biol. 2017 Feb 24;11(1):28. doi: 10.1186/s12918-016-0382-0. Network topology of NaV1.7 mutations in sodium channel-related painful disorders. Kapetis D1,2, Sassone J3,4, Yang Y5,6, Galbardi B7, Xenakis MN8,9, Westra RL8,9, Szklarczyk R8, Lindsey P8, Faber CG8,10, Gerrits M8, Merkies IS10,11,
Peripheral Nerve Stimulation of Brachial Plexus Nerve Roots and Supra-Scapular Nerve for Chronic Refractory Neuropathic Pain of the Upper Limb.
Neuromodulation. 2017 Feb 3. doi: 10.1111/ner.12573. Peripheral Nerve Stimulation of Brachial Plexus Nerve Roots and Supra-Scapular Nerve for Chronic Refractory Neuropathic Pain of the Upper Limb.Bouche B1, Manfiotto M2, Rigoard P3,4, Lemarie J5, Dix-Neuf V5, Lanteri-Minet M6,7,8, Fontaine D2,7. AbstractOBJECTIVES:We report
Analgesic effects of mambalgin peptide inhibitors of acid-sensing ion channels in inflammatory and neuropathic pain.
Pain. 2016 Mar;157(3):552-9. doi: 10.1097/j.pain.0000000000000397. Analgesic effects of mambalgin peptide inhibitors of acid-sensing ion channels in inflammatory and neuropathic pain. Diochot S1, Alloui A, Rodrigues P, Dauvois M, Friend V, Aissouni Y, Eschalier A, Lingueglia E, Baron A. Abstract Mambalgins